SCHEMBL17352007

SCHEMBL17352007

CC(C)NC(=O)C1CCCNC1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
ALDH1A1 P00352 1/20 0.54
POLB P06746 2/20 0.50
HTT P42858 1/20 0.50
HSD17B10 Q99714 1/20 0.48
KLK5 Q9Y337 1/20 0.48
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
KMT2A Q03164 1/20 0.47
HDAC3 O15379 3/20 0.46
HDAC1 Q13547 3/20 0.46
HDAC2 Q92769 3/20 0.46
HDAC10 Q969S8 3/20 0.46
HDAC11 Q96DB2 3/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
GAA P10253 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12376717 0.91 ACACB (0.47) L3MBTL1ALDH1A1POLBHTTHSD17B10
SCHEMBL23210378 0.79 L3MBTL1 (0.55) L3MBTL1ALDH1A1POLBHTTHSD17B10
SCHEMBL19586906 0.78 L3MBTL1 (0.46) L3MBTL1ALDH1A1POLBHTTHSD17B10
SCHEMBL17351999 0.76 L3MBTL1 (0.52) L3MBTL1ALDH1A1POLBHTTHSD17B10
SCHEMBL9307258 0.76 L3MBTL1 (0.59) L3MBTL1ALDH1A1POLBHTTHSD17B10
SCHEMBL12409535 0.76 ACACB (0.55) L3MBTL1ALDH1A1HTTHSD17B10KMT2A
SCHEMBL2789189 0.75 L3MBTL1 (0.54) L3MBTL1ALDH1A1POLBHTTHSD17B10
SCHEMBL17352003 0.75 L3MBTL1 (0.51) L3MBTL1ALDH1A1POLBHTTHSD17B10
SCHEMBL14811830 0.74 L3MBTL1 (0.61) L3MBTL1ALDH1A1POLBHTTHSD17B10
SCHEMBL55591 0.74 L3MBTL1 (0.61) L3MBTL1ALDH1A1POLBHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015199987-A1 SWEETENER ENHANCERS AND METHODS FOR USING THE SAME INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2015-12-30 WO disclosed
WO-2015199987-A1 SWEETENER ENHANCERS AND METHODS FOR USING THE SAME INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2015-12-30 WO disclosed
US-20150366252-A1 SWEETENER ENHANCERS AND METHODS FOR USING THE SAME INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2015-12-24 US disclosed
US-20150366252-A1 SWEETENER ENHANCERS AND METHODS FOR USING THE SAME INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2015-12-24 US disclosed
US-20150366252-A1 SWEETENER ENHANCERS AND METHODS FOR USING THE SAME INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366252-A1 SWEETENER ENHANCERS AND METHODS FOR USING THE SAME TAS2R60, TAS1R1, TAS2R1 L3MBTL1 1859/4885ALDH1A1 2410/4885POLB 4142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.